Discovery 670 DR Model # H3100BT

FDA Device Recall #Z-2996-2020 — Class II — August 14, 2020

Recall Summary

Recall Number Z-2996-2020
Classification Class II — Moderate risk
Date Initiated August 14, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm GE Healthcare, LLC
Location Waukesha, WI
Product Type Devices
Quantity 20 units

Product Description

Discovery 670 DR Model # H3100BT

Reason for Recall

Rotor bearing screws were found loose on detector.

Distribution Pattern

USA : AR CT FL GA IL KS KY LA MA MD MI MN MO NE NJ NV NY OH OK RI SC TN TX VA VT WA WI OUS: ARGENTINA AUSTRIA BELGIUM BRAZIL Canada CHINA FRANCE GERMANY GREECE INDIA ISRAEL ITALY JAPAN Korea (Republic of) NETHERLANDS NORWAY PANAMA POLAND PORTUGAL Russia SPAIN SWEDEN SWITZERLAND TAIWAN THAILAND TURKEY UNITED KINGDOM VIETNAM

Lot / Code Information

Serial # DRGX56002 System ID: 4445804NM11 Serial # DRGX56005 System ID: 614CVA6702CT Serial # DRGX56004 System ID: 403343D670A Serial # DRGX56017 System ID: 110002NU06 Serial # DRGX56018 System ID: X7410502 Serial # DRGX56003 System ID: 403438NU02 Serial # DRGX56010 System ID: UC4097NU02 Serial # DRGX56008 System ID: 826251NU01 Serial # DRGX56007 System ID: H2101NUC35 Serial # DRGX56006 System ID: 083026063363718 Serial # DRGX56011 System ID: 083026281900218 Serial # DRGX56009 System ID: 083049206531619 Serial # DRGX56021 System ID: 083026603411518 Serial # DRGX56019 System ID: A220806209 Serial # DRGX56012 System ID: STD01300 Serial # DRGX56014 Not Available Serial # DRGX56016 System ID: GEE34069 Serial # DRGX56020 System ID: DEL26498 Serial # DRGX56022 System ID: DE6588153 Serial # DRGX56015 System ID: 0853260202

Other Recalls from GE Healthcare, LLC

Recall # Classification Product Date
Z-1566-2022 Class II (1) GE Centricity Universal Viewer 6.0, Model 2... Jul 15, 2022
Z-1430-2022 Class II SIGNA Premier magnetic resonance scanner, model... Jun 24, 2022
Z-1466-2022 Class II Centricity PACS Software Version 7.0 SP0.0.4.7 Jun 14, 2022
Z-1333-2022 Class II GE Centricity Universal Viewer Zero Footprint. ... Jun 8, 2022
Z-1511-2022 Class II Service manuals for the CT, PET, or NM table as... Jun 2, 2022

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.